Millennium Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,004,795
| Closed | -$82M | – | 4727 |
|
|
2024
Q2 | $82M | Buy |
2,004,795
+531,972
| +36% | +$21.8M | 0.04% | 344 |
|
|
2024
Q1 | $62.3M | Buy |
1,472,823
+361,711
| +33% | +$15.3M | 0.03% | 446 |
|
|
2023
Q4 | $47.1M | Sell |
1,111,112
-1,018,701
| -48% | -$43.2M | 0.02% | 535 |
|
|
2023
Q3 | $46.5M | Buy |
2,129,813
+1,950,018
| +1,085% | +$42.6M | 0.02% | 488 |
|
|
2023
Q2 | $5.72M | Sell |
179,795
-285,195
| -61% | -$9.07M | ﹤0.01% | 1852 |
|
|
2023
Q1 | $11.3M | Buy |
+464,990
| New | +$11.3M | 0.01% | 1326 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5498 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5784 |
|
|
2022
Q2 | – | Sell |
-45,371
| Closed | -$1.59M | – | 5872 |
|
|
2022
Q1 | $1.59M | Sell |
45,371
-15,231
| -25% | -$533K | ﹤0.01% | 3227 |
|
|
2021
Q4 | $1.97M | Buy |
60,602
+48,332
| +394% | +$1.57M | ﹤0.01% | 2972 |
|
|
2021
Q3 | $362K | Buy |
+12,270
| New | +$362K | ﹤0.01% | 4409 |
|
|
2021
Q2 | – | Sell |
-426,016
| Closed | -$5.85M | – | 5464 |
|
|
2021
Q1 | $5.85M | Buy |
426,016
+386,444
| +977% | +$5.31M | ﹤0.01% | 1923 |
|
|
2020
Q4 | $656K | Buy |
+39,572
| New | +$656K | ﹤0.01% | 3102 |
|